Rheon Medical

Rheon Medical is a Swiss medical technology company that specializes in innovative surgical devices for glaucoma treatment. Founded as a spin-off from the Swiss Institute of Technology in Lausanne (EPFL), the company is led by a team with extensive expertise in ophthalmology. Rheon Medical aims to lead the glaucoma device market by developing technologies that enhance treatment efficacy and minimize complications. The company's flagship product, the eyeWatch glaucoma shunt, is an adjustable implant designed to effectively manage intraocular pressure while preventing early hypotony, a common complication in glaucoma surgery. This device allows for postoperative flow adjustments tailored to individual patient needs and has received CE marking for the European market, along with the FDA’s “Breakthrough Device” designation in the United States. Additionally, Rheon Medical is developing the eyePlate-S, another implant that is pending regulatory approval in the EU. Rheon Medical emphasizes collaboration with healthcare professionals and researchers to ensure high safety and quality standards in its products. The company is committed to innovation, excellence, ethics, and collaboration in advancing glaucoma treatment.

• Employees 6
• Founded 2010
• Total Funding $6304590